Logos Global Management’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.51M Sell
611,914
-325,000
-35% -$3.99M 0.83% 31
2025
Q1
$10.3M Buy
+936,914
New +$10.3M 1.83% 21